Zacks Investment Research Analysis

Garrison Capital (GARS) Lags Q4 Earnings And Revenue Estimates By Zacks Investment Research - Mar 12, 2020

Garrison Capital (GARS) came out with quarterly earnings of $0.16 per share, missing the Zacks Consensus Estimate of $0.17 per share. This compares to earnings of $0.20 per share a year ago. These...

Rockwell Medical (RMTI) Reports Q4 Loss, Misses Revenue Estimates By Zacks Investment Research - Mar 12, 2020

Rockwell Medical (RMTI) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to loss of $0.15 per share a year ago. These figures are...

Caleres Inc. (CAL) Q4 Earnings And Revenues Surpass Estimates By Zacks Investment Research - Mar 12, 2020

Caleres Inc. (CAL) came out with quarterly earnings of $0.34 per share, beating the Zacks Consensus Estimate of $0.20 per share. This compares to earnings of $0.38 per share a year ago. These figures...

Lineage Cell (LCTX) Reports Q4 Loss, Tops Revenue Estimates By Zacks Investment Research - Mar 12, 2020

Lineage Cell (LCTX) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to loss of $0.07 per share a year ago. These figures are...

How The Coronavirus Has Impacted Earnings By Zacks Investment Research - Mar 12, 2020

Note: The following is an excerpt from this week’s Earnings Trends report. You can access the full report that contains detailed historical actual and estimates for the current and following...

Iridex (IRIX) Reports Q4 Loss, Tops Revenue Estimates By Zacks Investment Research - Mar 12, 2020

Iridex (IRIX) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.16. This compares to loss of $0.21 per share a year ago. These figures are adjusted...

Geron (GERN) Reports Q4 Loss, Tops Revenue Estimates By Zacks Investment Research - Mar 12, 2020

Geron (GERN) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.20. This compares to loss of $0.05 per share a year ago. These figures are adjusted...

Flexion Therapeutics (FLXN) Reports Q4 Loss, Tops Revenue Estimates By Zacks Investment Research - Mar 12, 2020

Flexion Therapeutics (FLXN) came out with a quarterly loss of $0.88 per share versus the Zacks Consensus Estimate of a loss of $1.01. This compares to loss of $1.07 per share a year ago. These figures...

Senseonics Holdings (SENS) Reports Q4 Loss, Tops Revenue Estimates By Zacks Investment Research - Mar 12, 2020

Senseonics Holdings (SENS) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.16. This compares to loss of $0.04 per share a year ago. These figures...

DocuSign (DOCU) Q4 Earnings And Revenues Surpass Estimates By Zacks Investment Research - Mar 12, 2020

DocuSign (DOCU) came out with quarterly earnings of $0.12 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.06 per share a year ago. These figures are...

COREPOINT LODGE (CPLG) Tops Q4 FFO And Revenue Estimates By Zacks Investment Research - Mar 12, 2020

COREPOINT LODGE (CPLG) came out with quarterly funds from operations (FFO) of $0.17 per share, beating the Zacks Consensus Estimate of $0.07 per share. This compares to FFO of $0.35 per share a year...

Golden Entertainment (GDEN) Reports Q4 Loss, Tops Revenue Estimates By Zacks Investment Research - Mar 12, 2020

Golden Entertainment (GDEN) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.20. This compares to loss of $0.64 per share a year ago. These figures...

The 11-Year Bull Run Is Coming To An End By Zacks Investment Research - Mar 12, 2020

The coronavirus has pushed stocks into a bear market with the Dow dropping below its 2018 lows. President Trump officially shut our borders to Europe, sending equities into a free fall after-hours....

Amphastar Pharmaceuticals (AMPH) Q4 Earnings And Revenues Beat Estimates By Zacks Investment Research - Mar 12, 2020

Amphastar Pharmaceuticals (AMPH) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.13 per share a year ago....

Buy AT&T (T) Stock For Its Dividend & Buybacks Amid Coronavirus Selloff? By Zacks Investment Research - Mar 12, 2020

The market’s 11-year bull run is over, after the Dow, the S&P 500, and the Nasdaq all tumbled again Thursday. This downturn came the day after the World Health Organization declared the...

Bear Of The Day: Rogers Corporation (ROG) By Zacks Investment Research - Mar 12, 2020

Rogers Corporation (ROG) is a Zacks Rank #5 (Strong Sell) that is a global leader in engineered materials to power, protect and connect the world. The company delivers high-performance solutions that...

Bull Of The Day: Lyft (LYFT) By Zacks Investment Research - Mar 12, 2020

Lyft (NASDAQ:LYFT) (LYFT) has lost almost 50% since its Q4 earnings on February 11th. The initial drop-off was an over-exaggeration by the markets, and the coronavirus continues to pull these shares...